Sagar Doshi of Edelweiss Financial Services has a buy call on Sun Pharmaceutical Industries Ltd. with a target price of Rs 455.0 . The current price of Sun Pharmaceutical Industries Ltd. is Rs 429.7 Time period given by the analyst is Intra Day when Sun Pharmaceutical Industries Ltd. price can reach defined target. Sagar Doshi recommended to keep a stoploss at Rs 410 .
Sun Pharmaceutical Industries Ltd., incorporated in 1993, has a market cap of Rs 103099.42 crore.
Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9783.29 Crore to Sales Value (94.95 % of Total Sales) and Other Operating Revenue which contributed Rs 519.92 Crore to Sales Value (5.04 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 7949.19 Crore, down -3.75 % from last quarter Sales of Rs 8259.30 Crore and up 16.11 % from last year same quarter Sales of Rs 6846.48 Crore Company has reported net profit after tax of Rs 1167.35 Crore in latest quarter.
The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Company has S R B C & Co. LLP as its auditors. As on 30-09-2019, the company has a total of 2,399,334,970 shares outstanding.
Source: Economic Times
